ConductScience.org, home

Paper3970320

Ranitidine as an inhibitor of liver regeneration.

Kanashima R and 2 others. Am J Surg, 1985. Cited by 16 papers, by iCite.

Cite this record

ConductScience Library. Ranitidine as an inhibitor of liver regeneration. Papers, record 3970320. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3970320

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Ranitidine as an inhibitor of liver regeneration.
PubMed
Journal
Am J Surg
PubMed
Year
1985
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
16
iCite
Relative citation ratio, by iCite
0.92
iCite
Revised in PubMed
2019-06-27
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Kanashima RR
2Nagasue NN
3Sakato KK

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Growth InhibitorsMajor topic
Liver RegenerationMajor topic
RanitidineMajor topic
Animals
Cell Division
Chemical and Drug Induced Liver Injury
Female
Hepatectomy
Liver Circulation
Liver Diseases
Rats
Rats, Inbred Strains

Source PubMed

Download CSV of topics

Cited by7

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 16 citations.

PMIDTitleJournalYearIn PapersSource
29236753Effects of genetic polymorphisms on the OCT1 and OCT2-mediated uptake of ranitidine.PLoS One2017https://conductscience.org/library/papers/29236753PubMed
23839564Famotidine lessens carbon tetrachloride-induced liver damage in rats: A possible implication in lessening volatile anesthetics-induced liver damage.J Anesth1996https://conductscience.org/library/papers/23839564PubMed
8555701The liver regenerative response elicited by antisecretory agents in partially hepatectomized rats: a comparison between omeprazole and famotidine.Surg Today1995https://conductscience.org/library/papers/8555701PubMed
7859585Safety of acid-suppressing drugs.Dig Dis Sci1995https://conductscience.org/library/papers/7859585PubMed
3397626Effect of an antiandrogenic H2 receptor antagonist on hepatic regeneration in rats.J Lab Clin Med1988https://conductscience.org/library/papers/3397626PubMed
2878343Adverse reactions and interactions with H2-receptor antagonists.Med Toxicol1986https://conductscience.org/library/papers/2878343PubMed
2564010Effect of cimetidine, ranitidine, famotidine and omeprazole on hepatocyte proliferation in vitro.J Hepatol1989https://conductscience.org/library/papers/2564010PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/3970320

GET https://conductscience.org/api/papers/v1/3970320/authors